Sandoz's Erelzi has become the first biosimilar of Amgen's Enbrel (etanercept ... in all uses included in the reference product label – allowing the Novartis unit to compete against a product ...

The appeals court ruling blocks Sandoz from producing a biosimilar of Enbrel (etanercept) until 2029, more than thirty years after it was first approved. Sandoz, which is the biosimilars and ...